Colesevelam Versus Placebo in Cholestatic Pruritus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

December 31, 2009

Conditions
Chronic Liver Disease
Interventions
DRUG

colesevelam

2 times 3 625 mg tablets daily, 3 weeks

DRUG

placebo

2 times 3 625mg tablets daily

Trial Locations (3)

Unknown

Amsterdam Medical Center, Amsterdam

Erasmus Medical Center, Rotterdam

University Medical Center Utrecht, Utrecht

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER

NCT00756171 - Colesevelam Versus Placebo in Cholestatic Pruritus | Biotech Hunter | Biotech Hunter